India, Egypt Strengthen Pharmaceutical Collaboration Through High-Level Delegation Visit

(MENAFN- Daily News Egypt) A high-level Indian delegation, led by Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), and accompanied by Shri Suresh K. Reddy, Ambassador of India to Egypt, held meetings on Sunday with key stakeholders in Egypt's rapidly expanding pharmaceutical sector, as part of efforts to strengthen bilateral cooperation and trade.

The visit aims to deepen collaboration between India and Egypt and explore new opportunities for joint ventures, technology transfer, and capacity-building across the healthcare and pharmaceutical industries.

The delegation includes senior representatives from India's pharmaceutical industry and is focused on opportunities in generics, biosimilars, and vaccines-areas in which India has established global leadership. Egypt's pharmaceutical market, projected to grow from $5.1bn in 2024-25 to $5.7bn in 2025-26, presents significant potential for strategic partnerships and investment.

Ambassador Reddy highlighted the growing momentum in India-Egypt pharmaceutical relations, stating:“India has long been a trusted partner in the global pharmaceutical industry, and Egypt's dynamic healthcare sector offers an ideal platform for deeper collaboration. The Embassy remains committed to facilitating partnerships that benefit not only our two countries, but also the wider MENA region.”

Raja Bhanu underscored India's role in supporting Egypt's healthcare ambitions, noting:“India's pharmaceutical industry is known for delivering high-quality, affordable medicines. As Egypt expands healthcare coverage and strengthens local manufacturing capacity, Indian companies are well positioned to collaborate with Egyptian counterparts, helping to improve access to essential medicines for all.”

The cooperation will focus on several priority areas, including generic medicines, clinical research, biotechnology, and vaccine production. Both countries are exploring joint ventures in pharmaceutical manufacturing and research and development, with the aim of positioning Egypt as a regional hub for pharmaceutical production and trade.

The visit also marks the launch of new initiatives designed to stimulate investment, promote knowledge exchange, and drive innovation in the healthcare sector. Pharmexcil and the Indian Embassy will continue to work closely to support India-Egypt partnerships, leveraging shared expertise and mutual opportunities to strengthen the pharmaceutical industries of both nations.

MENAFN11012026000153011029ID1110584479